Case series: effects of an induced molting protocol using levothyroxine in five captive banded penguins (genus Spheniscus)

Penguin molts occur annually after breeding, allowing effective waterproofing and temperature regulation. However, aberrant molts frequently occur in penguins, which can lead to health problems if prolonged. Although the exact mechanisms underlying molting in birds remain unclear, some studies have focused on the roles of thyroid and sex hormones in penguins. Previous studies on forced molting using hormonal treatments have shown both success and failure. In particular, the use of synthetic thyroxine (levothyroxine) has mostly not been successful. This study aimed to induce molting by administering commercial levothyroxine to one Humboldt penguin (<i>Spheniscus humboldti</i>) and four African penguins (<i>Spheniscus demersus</i>) with abnormal molting, housed in aquaria. The planned levothyroxine dosing protocol was to start with 25 μg/kg PO q24h for 7 d, then increase it gradually to 50 μg/kg PO q24h for the next 7 d and 75 μg/kg PO q24h for 7 d, followed by a gradual decrease to 50 μg/kg PO q24h for 7 d, and 25 μg/kg PO q24h for the final 7 d. Three penguins received treatment according to this scheduled protocol, two of which initiated molting during the dosing period, while the third began to molt approximately 3 months post-treatment. Another penguin was administered the maximum dose for an additional week, which led to molting in the final week of treatment. In the remaining penguin, the medication was deemed to be insufficiently absorbed because of inadequate drug delivery methods. Consequently, the drug delivery strategy was changed during the 5<sup>th</sup> week of treatment, and the treatment was extended for an additional 3 weeks beyond the original plan, after which the penguin began to molt. Therefore, all five penguins in this study exhibited molting following oral levothyroxine treatment, suggesting that this is a potential option for inducing molting in banded penguins (<i>Spheniscus</i> sp.) experiencing aberrant molt.

Authors

Institutions

Publication Details

Journal
Frontiers in Veterinary Science
Published
2025-09-10
DOI
https://doi.org/10.3389/fvets.2025.1544599
Primary Topic
Bird parasitology and diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case series: effects of an induced molting protocol using levothyroxine in five captive banded penguins (genus Spheniscus)

Sang Wha Kim, Yeong-Hun Kang, Jina Park, Seunghyun Seo
Frontiers in Veterinary Science
Bird parasitology and diseases
article

Case series: effects of an induced molting protocol using levothyroxine in five captive banded penguins (genus Spheniscus)

Sang Wha Kim, Yeong-Hun Kang, Jina Park, Seunghyun Seo
article en

Abstract

Penguin molts occur annually after breeding, allowing effective waterproofing and temperature regulation. However, aberrant molts frequently occur in penguins, which can lead to health problems if prolonged. Although the exact mechanisms underlying molting in birds remain unclear, some studies have focused on the roles of thyroid and sex hormones in penguins. Previous studies on forced molting using hormonal treatments have shown both success and failure. In particular, the use of synthetic thyroxine (levothyroxine) has mostly not been successful. This study aimed to induce molting by administering commercial levothyroxine to one Humboldt penguin (<i>Spheniscus humboldti</i>) and four African penguins (<i>Spheniscus demersus</i>) with abnormal molting, housed in aquaria. The planned levothyroxine dosing protocol was to start with 25 μg/kg PO q24h for 7 d, then increase it gradually to 50 μg/kg PO q24h for the next 7 d and 75 μg/kg PO q24h for 7 d, followed by a gradual decrease to 50 μg/kg PO q24h for 7 d, and 25 μg/kg PO q24h for the final 7 d. Three penguins received treatment according to this scheduled protocol, two of which initiated molting during the dosing period, while the third began to molt approximately 3 months post-treatment. Another penguin was administered the maximum dose for an additional week, which led to molting in the final week of treatment. In the remaining penguin, the medication was deemed to be insufficiently absorbed because of inadequate drug delivery methods. Consequently, the drug delivery strategy was changed during the 5<sup>th</sup> week of treatment, and the treatment was extended for an additional 3 weeks beyond the original plan, after which the penguin began to molt. Therefore, all five penguins in this study exhibited molting following oral levothyroxine treatment, suggesting that this is a potential option for inducing molting in banded penguins (<i>Spheniscus</i> sp.) experiencing aberrant molt.

Frontiers in Veterinary ScienceVol. 12
Kangwon National University (KR), Yeoju University (KR), Jeonbuk National University (KR)
National Research Foundation, National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Openalex Percentile: Top 75%
Bird parasitology and diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.